Benchmark Maintains Buy on Bio-Techne, Maintains $120 Price Target
Benchmark analyst Robert Wasserman maintains Bio-Techne (NASDAQ:TECH) with a Buy and maintains $120 price target.
SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $110
SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and lowers the price target from $125 to $110.
Keybanc Maintains Overweight on Bio-Techne, Lowers Price Target to $115
Keybanc analyst Paul Knight maintains Bio-Techne (NASDAQ:TECH) with a Overweight and lowers the price target from $125 to $115.
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Benzinga’s Top Ratings Upgrades, Downgrades For January 10, 2023
Upgrades Morgan Stanley upgraded the previous rating for Stem Inc (NYSE:STEM) from Equal-Weight to Overweight. In the third…
Deutsche Bank Initiates Coverage On Bio-Techne with Buy Rating, Announces Price Target of $100
Deutsche Bank analyst Justin Bowers initiates coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and announces Price Target of $100.
Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
Citigroup Upgrades Bio-Techne to Buy, Raises Price Target to $100
Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $81.25 to $100.
RBC Capital Initiates Coverage On Bio-Techne with Sector Perform Rating, Announces Price Target of $89
RBC Capital analyst Conor McNamara initiates coverage on Bio-Techne (NASDAQ:TECH) with a Sector Perform rating and announces Price Target of $89.
Stephens & Co. Maintains Overweight on Bio-Techne, Adjusts Price Target to $105 – 4-for-1 Stock Split
Stephens & Co. analyst Jacob Johnson maintains Bio-Techne (NASDAQ:TECH) with a Overweight, adjusts price target to $105 - 4-for-1 stock split.